Mission
To lead in the export of sustainable medical cannabis cultivation and the production of high-quality ingredients for the pharmaceutical, therapeutic, and nutraceutical industries into a regulated international marketplace.
Cultivating excellence through innovation, sustainability, and global pharmaceutical standards. Pharmaceutical-grade medical cannabis, grown at altitude, exported to regulated markets worldwide.
Ocsas Pharma operates cultivation and processing facilities across Africa, strategically located in environments that provide optimal conditions for producing premium medical cannabis.
We adhere to strict CUMCS-GAP and GACP standards, working in collaboration with EU-GMP certified processing partners to deliver medical-grade cannabis products to pharmaceutical and therapeutic markets in Europe and beyond.
Our commitment to quality, sustainability, and regulatory excellence ensures we meet the highest international standards at every stage of production.
Read about our standards →Three commitments that guide every cultivation cycle, every batch, every export.
To lead in the export of sustainable medical cannabis cultivation and the production of high-quality ingredients for the pharmaceutical, therapeutic, and nutraceutical industries into a regulated international marketplace.
To cultivate and supply unique strains tailored to the needs of our offtake partners, collaborating with leading global universities for R&D to ensure ongoing innovation in flower and extract.
We are building successful commercial cultivation facilities and vertically integrated, recognizable brands in a rapidly growing global industry.
A best-practice production plan established and implemented in accordance with EU Good Manufacturing Practices and in full compliance with CUMCS-GMP standards.
Cultivar detail · greenhouse harvest
Cost-effective production not only reflects our values around medical cannabis accessibility for all, but also positions us as a highly competitive supplier to international markets without compromising on medicinal quality.
In-house QA/QC laboratory
Our best-practice production plan was established and implemented in accordance with EU Good Manufacturing Practices (EU-GMP) and in full compliance with CUMCS-GMP standards. Every batch is documented, tested, and traceable.
Cross-continental export operations
With facilities that serve as a benchmark for the European medical cannabis market, Ocsas Pharma produces medical cannabis products of the highest quality and makes them accessible to patients and partners throughout the EU and beyond.
Hybrid greenhouse environment optimized for African altitude and climate, with 30,000 square meters of dedicated production space.
Greenhouses sited at 2,200 meters above sea level, where natural conditions guarantee terpene density and flower integrity.
Active operations across Rwanda, Malawi, Morocco, and Ghana, coordinated from our head office in Toronto, Canada.
Coordinated from Toronto. Cultivated across Africa. Exported to regulated international markets.
For procurement enquiries and partnership conversations, our team is ready to discuss specifications, certifications, and timelines.